Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
– 29 –<br />
Why <strong>Agricultural</strong> <strong>Biotechnology</strong>?<br />
Pacific countries, including China and India, the regulation of traits combined by conventional<br />
breeding is under consideration.<br />
In contrast, the European Union and Argentina consider combined-trait products to be<br />
novel or unique and there<strong>for</strong>e require a new submission or the inclusion of the <strong>for</strong>eseen combined-trait<br />
products in the submission of one of the parents. Extensive bridging regulatory data<br />
on the combined-trait products needs to be generated. No combined-trait products produced<br />
through conventional breeding have been approved to date in either the EU or Argentina.<br />
A reasonable regulatory approach <strong>for</strong> combined-trait products is set <strong>for</strong>th in a document<br />
prepared by scientists and regulatory specialists from member companies of CropLife International<br />
(CropLife International, 2005). Separate safety assessments should not be required if the<br />
individual traits are unrelated and the individual traits were previously approved. However, to<br />
confirm the presence of the individual traits in the combined-trait product, regulatory agencies<br />
might request greenhouse or field bioefficacy data or gene expression levels. Data from any one<br />
of these sources would be appropriate to demonstrate that the individual traits are present and<br />
functioning as intended in the combined-trait product. Additional safety data are scientifically<br />
justified only when the traits target the same metabolic pathway or they are otherwise expected<br />
to have interactions. On a case-by-case basis, studies may be required to determine whether there<br />
are any interactions, either synergistic or antagonistic, between the traits, or to assess the products<br />
of the metabolic pathway.<br />
Reasonable rules <strong>for</strong> the review of crops with biotechnology-derived traits combined by<br />
conventional breeding will preserve the significant benefits of these technologies. For example,<br />
combining traits by conventional breeding would allow the combination of traits that have<br />
region- or country-specific uses but may not justify the expense of separate development through<br />
plant trans<strong>for</strong>mation. Additionally, reasonable regulations that are consistent between trading<br />
countries and regions will facilitate the movement of commodities containing these traits.<br />
CONCLUSION<br />
As described herein, crops developed through agricultural biotechnology have provided<br />
demonstrable economic, environmental, and social benefits globally. Within the Asia–Pacific<br />
region, five countries have grown biotechnology-derived crops commercially: Australia, China,<br />
India, Indonesia, and the Philippines. Specific examples described insect-protected cotton in<br />
China, Australia, and India, insect-protected maize in the Philippines, and herbicide-tolerant cotton<br />
in Australia. Future uses in the Asia–Pacific region include more widespread adoption of<br />
herbicide-tolerant crops currently grown elsewhere, including herbicide-tolerant maize. In addition,<br />
China and India have very active crop biotechnology research and development programs<br />
in a diversity of crops (including chickpea, rice, cotton, maize, mustard, and potato) and biotechnology<br />
traits (including insect, disease, and virus resistance, herbicide tolerance, stress tolerance,<br />
oil improvements, and fruit ripening). Other biotech-derived traits will improve food and<br />
feed nutrition, including vitamin and mineral enhancement, increased essential amino acids and<br />
altered fatty acid composition. However, the successful development and commercialization of<br />
biotech-derived crops will be impacted by the costs of doing so, and the costs of regulatory<br />
approvals have become an increasingly significant part of the total product development and<br />
commercialization equation. Regulators and the scientists who support them must make take<br />
care to assure that data requirements are reasonable and designed to address true food, feed, and<br />
environmental risks.<br />
REFERENCES<br />
Alia Hayashi H., Sakamoto A., Murata N. Enhancement of the tolerance of Arabidopsis to high<br />
temperatures by genetic engineering of the synthesis of glycinebetaine. Plant Journal 1998;<br />
16: 155–161.